| 13th week of 2020 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20200093754 | HYDROCARBON OIL FOR A THERAPEUTIC USE | 2020-03-26 |
| 20200093755 | PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABIDIOL AND BETA-CARYOPHYLLENE AND METHODS FOR THEIR USE | 2020-03-26 |
| 20200093756 | BUCKWHEAT HONEY AND POVIDONE-IODINE WOUND-HEALING DRESSING | 2020-03-26 |
| 20200093757 | METHOD FOR THE TREATMENT OF FATTY LIVER DISEASE | 2020-03-26 |
| 20200093758 | USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME | 2020-03-26 |
| 20200093759 | Method of Initiating and Escalating Sotalol Hydrochloride Dosing | 2020-03-26 |
| 20200093760 | DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION | 2020-03-26 |
| 20200093761 | DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION | 2020-03-26 |
| 20200093762 | COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC EFFECTS | 2020-03-26 |
| 20200093763 | HOMOTAURINE COMPOUNDS, COMPOSITIONS AND FORMULATIONS FOR ANIMAL CARE | 2020-03-26 |
| 20200093764 | TREATMENT OF ASTHMA WITH CYSTEAMINE | 2020-03-26 |
| 20200093765 | STABLE AQUEOUS CAPSAICIN INJECTABLE FORMULATIONS AND MEDICAL USES THEREOF | 2020-03-26 |
| 20200093766 | STABLE AQUEOUS CAPSAICIN INJECTABLE FORMULATIONS AND MEDICAL USES THEREOF | 2020-03-26 |
| 20200093767 | COMPOSITION CONTAINING GLIBENCLAMIDE | 2020-03-26 |
| 20200093768 | METHOD FOR TREATING DIABETES | 2020-03-26 |
| 20200093769 | NANOPARTICLE COMPOSITIONS, METHODS OF FABRICATION, AND USE FOR DRUG DELIVERY | 2020-03-26 |
| 20200093770 | Compositions and Methods for Promoting Bone Regeneration | 2020-03-26 |
| 20200093771 | ORAL COMBINATION DRUG FORMULATION COMPRISING A NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND A COMPLEMENTARY LOW DOSE OF TRANEXAMIC ACID FOR THE TREATMENT OF MENSTRUAL PAIN ACCOMPANIED WITH EXCESSIVE MENSTRUAL BLOOD LOSS | 2020-03-26 |
| 20200093772 | SUBSTANTIALLY SODIUM FREE DICLOFENAC POTASSIUM ORAL SOLUTIONS | 2020-03-26 |
| 20200093773 | Effects of Heparin on Topical Use of Plasters Containing a Non-Steroidal Anti-Inflammatory Drug | 2020-03-26 |
| 20200093774 | N-ACETYLCYSTEINE FOR USE AS ANTIBACTERIAL AGENT | 2020-03-26 |
| 20200093775 | Compositions And Methods For Treating Intestinal Hyperpermeability | 2020-03-26 |
| 20200093776 | MUCOSAL IMMUNOSTIMULATOR | 2020-03-26 |
| 20200093777 | METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT | 2020-03-26 |
| 20200093778 | METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT | 2020-03-26 |
| 20200093779 | Sickle Cell Disease Treatment Utilizing Omega-3 Fatty Acids | 2020-03-26 |
| 20200093780 | Compositions and Methods for Treating Autism Spectrum Disorders | 2020-03-26 |
| 20200093781 | BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES | 2020-03-26 |
| 20200093782 | ARIANTS OF 2-[6-(4-CHLOROPHENOXY)HEXYL]-OXIRANE-2-CARBOXYLIC ACID FOR USE IN THE TREATMENT, PREVENTION AND/OR AMELIORATION OF BRAIN DISEASES | 2020-03-26 |
| 20200093783 | Preparation and Anti-HepG2 Application for Urushiol-Based pH Response Micelle Encapsulating Paclitaxel | 2020-03-26 |
| 20200093784 | ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS | 2020-03-26 |
| 20200093785 | SKIN CARE COMPOSITIONS AND METHODS | 2020-03-26 |
| 20200093786 | SYNERGISTIC USE OF CANNABIS FOR TREATING MULTIPLE MYELOMA | 2020-03-26 |
| 20200093787 | Cannabinoid Compositions | 2020-03-26 |
| 20200093788 | Compounds and Methods for Inhibiting CPY26 Enzymes | 2020-03-26 |
| 20200093789 | Cancer Treatment with a CXCL12 Signaling Inhibitor and an Immune Checkpoint Inhibitor | 2020-03-26 |
| 20200093790 | PHARMACEUTICAL COMPOSITION COMPRISING OMEGA-3 FATTY ACID AND HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME | 2020-03-26 |
| 20200093791 | FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS | 2020-03-26 |
| 20200093792 | USE OF AMISULPRIDE AS AN ANTI-EMETIC | 2020-03-26 |
| 20200093793 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES | 2020-03-26 |
| 20200093794 | METHODS, AGENTS, AND COMPOSITIONS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA | 2020-03-26 |
| 20200093795 | PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA | 2020-03-26 |
| 20200093796 | METHODS OF TREATING INFLUENZA | 2020-03-26 |
| 20200093797 | Compounds and Compositions That Bind and Stabilize Transthyretin and Their Use for Inhibiting Transthyretin Amyloidosis and Protein-Protein Interactions | 2020-03-26 |
| 20200093798 | COMPOUNDS FOR THE TREATMENT OF ACUTE ORGAN INJURY | 2020-03-26 |
| 20200093799 | Peptides for Skin Rejuvenation and Methods of Using the Same | 2020-03-26 |
| 20200093800 | Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions | 2020-03-26 |
| 20200093801 | NEW METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS | 2020-03-26 |
| 20200093802 | BAX ACTIVATORS AND USES THEREOF IN CANCER THERAPY | 2020-03-26 |
| 20200093803 | TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION | 2020-03-26 |
| 20200093804 | PHARMACEUTICAL COMPOSITION OF EVEROLIMUS | 2020-03-26 |
| 20200093805 | TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILAST | 2020-03-26 |
| 20200093806 | USE OF GABOXADOL FOR THE TREATMENT OF TOURETTE SYNDROME, TICS AND STUTTERING | 2020-03-26 |
| 20200093807 | NEW USE OF RIFAMYCIN-NITROIMIDAZOLE CONJUGATE MOLECULE | 2020-03-26 |
| 20200093808 | Methods for the Administration of Certain VMAT2 Inhibitors | 2020-03-26 |
| 20200093809 | SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION | 2020-03-26 |
| 20200093810 | DEUTERIUM-ENRICHED PIRFENIDONE AND METHODS OF USE THEREOF | 2020-03-26 |
| 20200093811 | METHOD FOR TREATMENT OF DISEASE CAUSED OR AGGRAVATED BY MICROORGANISMS OR RELIEVING SYMPTOMS THEREOF | 2020-03-26 |
| 20200093812 | 5-[[4-[2-[5-(1-Hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazol- idine-2,4-dione for Treating Nonalcoholic Fatty Liver Disease | 2020-03-26 |
| 20200093813 | USE OF PRIDOPIDINE TO IMPROVE COGNITIVE FUNCTION AND FOR TREATING ALZHEIMER'S DISEASE | 2020-03-26 |
| 20200093814 | COMBINATION THERAPY WITH AMIDINE SUBSTITUTED BETA-LACTAM COMPOUNDS AND BETA-LACTAMASE INHIBITORS FOR INFECTIONS WITH ANTIBIOTIC RESISTANT BACTERIAL STRAINS | 2020-03-26 |
| 20200093815 | COMBINATIONS OF EZH2 INHIBITORS WITH FURTHER AGENTS FOR USE IN THE TREATMENT OF CANCER | 2020-03-26 |
| 20200093816 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTICS AGENTS | 2020-03-26 |
| 20200093818 | LIQUID NALOXONE SPRAY | 2020-03-26 |
| 20200093821 | Pharmaceutical Compositions of a Benzothiophene Compound | 2020-03-26 |
| 20200093822 | CRMP2 SUMOYLATION INHIBITORS AND USES THEREOF | 2020-03-26 |
| 20200093823 | METHOD OF TREATING BIPOLAR I AND II DISORDERS | 2020-03-26 |
| 20200093824 | ERBB3 Activators in Hearing Restoration | 2020-03-26 |
| 20200093825 | JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES | 2020-03-26 |
| 20200093826 | NEW USE OF TRIAZOLO(4,5 D)PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTION | 2020-03-26 |
| 20200093827 | Pemetrexed Polymeric Nanoparticles And Methods Of Making And Using Same | 2020-03-26 |
| 20200093828 | CDC-7-INHIBITOR COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS | 2020-03-26 |
| 20200093829 | METHOD FOR ENHANCING WOUND HEALING BY ADMINISTRATING ADENINE | 2020-03-26 |
| 20200093830 | METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER LUNG DISORDERS | 2020-03-26 |
| 20200093831 | DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases | 2020-03-26 |
| 20200093832 | METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 | 2020-03-26 |
| 20200093833 | METHODS AND COMPOSITIONS FOR IBOGAINE TREATMENT OF IMPULSE CONTROL DISORDER, ANXIETY-RELATED DISORDERS, VIOLENCE AND/OR ANGER, OR REGULATING FOOD INTAKE | 2020-03-26 |
| 20200093834 | COMPOSITIONS FOR DELIVERING A BIO-ACTIVE AGENT OR BIO-ACTIVE AGENTS | 2020-03-26 |
| 20200093835 | METHODS OF TREATING VESTIBULAR SCHWANNOMA | 2020-03-26 |
| 20200093836 | ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME | 2020-03-26 |
| 20200093837 | Composition for Curing Migraine Headaches | 2020-03-26 |
| 20200093838 | METHODS FOR TREATING AND PREVENTING ALLERGIES AND ACUTE ALLERGIC RESPONSES | 2020-03-26 |
| 20200093839 | HALOGENATED SALICYLANILIDES FOR TREATING CLOSTRIDIUM INFECTIONS | 2020-03-26 |
| 20200093840 | DARUNAVIR COMBINATION FORMULATIONS | 2020-03-26 |
| 20200093841 | Broad Spectrum Antiviral and Methods of Use | 2020-03-26 |
| 20200093842 | NOVEL TREATMENTS FOR FREE-LIVING AMOEBIC INFECTIONS | 2020-03-26 |
| 20200093843 | COMPOUNDS FOR TREATMENT OF INTRACTABLE EPILEPSY AND DOORS SYNDROME | 2020-03-26 |
| 20200093844 | CD73 INHIBITORS | 2020-03-26 |
| 20200093845 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | 2020-03-26 |
| 20200093846 | METHODS FOR DECREASING THE INCIDENCE OF NECROTIZING ENTEROCOLITIS IN INFANTS, TODDLERS, OR CHILDREN USING HUMAN MILK OLIGOSACCHARIDES | 2020-03-26 |
| 20200093847 | HUMAN MILK OLIGOSACCHARIDES TO PROMOTE GROWTH OF BENEFICIAL BACTERIA | 2020-03-26 |
| 20200093848 | POLYMORPHIC COMPOUNDS AND USES THEREOF | 2020-03-26 |
| 20200093849 | URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME | 2020-03-26 |
| 20200093850 | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF CHRONIC DISEASE | 2020-03-26 |
| 20200093851 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | 2020-03-26 |
| 20200093852 | Methods of Treating Ocular Disorders | 2020-03-26 |
| 20200093853 | COMPOSITIONS AND METHODS FOR TREATMENT OF LOSS OF FLUIDS LEADING TO HYPOTENSION AND/OR HYPOVOLEMIA | 2020-03-26 |
| 20200093854 | METHODS AND COMPOSITIONS FOR EYE CARE | 2020-03-26 |
| 20200093855 | ENHANCED IMMUNE RESPONSE UPON TREATMENT WITH NITRIC OXIDE | 2020-03-26 |
| 20200093856 | Hydrogen-containing composition for ameliorating depressive symptom | 2020-03-26 |
